Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Inflammation induces pro-NETotic neutrophils via TNFR2 signaling (2022) Neuenfeldt F, Schumacher JC, Grieshaber-Bouyer R, Habicht J, Schröder-Braunstein J, Gauss A, Merle U, et al. Journal article First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B (2022) Gehlen J, Giel AS, Köllges R, Haas SL, Zhang R, Trcka J, Sungur A, et al. Journal article Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation (2022) Polymeris AA, Meinel TR, Oehler H, Hoelscher K, Zietz A, Scheitz JF, Nolte CH, et al. Journal article Patient Recruitment System for Clinical Trials: Mixed Methods Study About Requirements at Ten University Hospitals (2022) Fitzer K, Haeuslschmid R, Blasini R, Altun FB, Hampf C, Freiesleben S, Macho P, et al. Journal article Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases (2022) Styczen H, Maus V, Goertz L, Koehrmann M, Kleinschnitz C, Fischer S, Moehlenbruch M, et al. Journal article The prognostic impact of Claudin 6 in papillary renal cell carcinoma (2022) Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article cMET: a prognostic marker in papillary renal cell carcinoma? (2022) Erlmeier F, Bruecher B, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Towards a better treatment of patients with vascular malformations: certified interdisciplinary centers are mandatory* (2022) Cucuruz B, Koller M, Pfleiderer R, Geisthoff U, Meyer L, Kapp F, Lang W, et al. Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution